Results 291 to 300 of about 123,600 (352)

Validation of clinicopathologic features of a genetic myelodysplastic syndrome classification in an independent cohort. [PDF]

J Hematop
Patwardhan PP, Al Amri RD, Baloda V, Aarabi M, Aggarwal N, Djokic M, Monaghan SA, Moore EM, Rea B, Bailey NG.   +9 more
europepmc   +1 more source

Peripheral versus Marrow Lipidomics in Patients with Severe Aplastic Anemia: Potential Indicators for Early Immunosuppressive Treatment Response

Lipids, Volume 61, Issue 3, Page 347-361, May 2026.
ABSTRACT This study aimed to explore the differences of peripheral blood (PB) and bone marrow serum lipidomic profiles in severe aplastic anemia (SAA) patients and their significance in predicting earlier immunosuppressive therapy (IST) response. A cohort of 11 newly diagnosed SAA patients and 15 healthy controls were enrolled between June 2020 and ...
Zexing Sun, Yilei Hong, Yaonan Hong, Chuanao Xin, Qi Liu, Huijin Hu, Yingying Shen, Ying Chen, Shan Liu, Yiping Shen, Yuhong Zhou, Dijiong Wu   +11 more
wiley   +1 more source

Myeloid Sarcoma Mimicking Intramuscular Abscesses in a Patient With Myelodysplastic Syndrome: A Diagnostic Challenge. [PDF]

Cureus
Mourato M, Machado M, Achega M, Penaforte R, Negrão C.   +4 more
europepmc   +1 more source

Isocitrate Dehydrogenase Mutations in Cancer: From Bench to Bedside Applications

MedComm, Volume 7, Issue 5, May 2026.
Mutant isocitrate dehydrogenase affects multiple cancer types. Alterations in IDH1 and IDH2 result in abnormal enzyme activity, leading to the overproduction of D‐2‐hydroxyglutarate (D‐2HG). This metabolite disrupts cellular metabolism and epigenetic regulation, driving cancer initiation, progression, and metastasis.
Yuhan Fang, Xiaoqing Wang, Kai Luo, Tikam Chand Dakal, He Bai, Caiming Xu, Guixin Zhang   +6 more
wiley   +1 more source

A Case of VEXAS Syndrome Initially Masked as Myelodysplastic Syndrome: Importance of Marrow Vacuolization and UBA1 Testing: A Case Report. [PDF]

Am J Case Rep
Shahverdi E, Mundmann P, Pohlkamp C, Dirare S, Hussein Mohamed I, Semerci H, Petz C.   +6 more
europepmc   +1 more source

Collapsing Glomerulopathy in a Patient With Myelodysplastic Syndrome With Isolated del(5q): A Case Report. [PDF]

Kidney Med
Naruemon N, Iamsai P, Ounpanyo P, Cheunsuchon B, Vongchaiudomchoke T.   +4 more
europepmc   +1 more source

Chromatin accessibility in stem cells unveils progressive transcriptional alterations in myelodysplastic syndrome. [PDF]

Nat Commun
Oshima M, Takayama N, Nakajima-Takagi Y, Shinoda D, Itokawa N, Kurosawa S, Kaito S, Kamiya T, Yamada Y, Andoh S, Kayamori K, Paul SK, Kanashiro MA, Muto T, Tsukamoto S, Sakaida E, Sato E, Yusa N, Yokoyama K, Nannya Y, Imoto S, Rahmutulla B, Kaneda A, Yamaguchi K, Furukawa Y, Doki N, Eto K, Nishikawa K, Ding Y, Myojo T, Harada Y, Harada H, Iwama A.   +32 more
europepmc   +1 more source

Clinical Utility of Multiplex Ligation-Dependent Probe Amplification in the Genetic Assessment of Patients with Myelodysplastic Syndrome. [PDF]

Biomedicines
Valeva R, Levkova M, Yahya D, Hachmeriyan M, Micheva I.   +4 more
europepmc   +1 more source

One Grammar, Many Labels: Revisiting the Continuum of Myeloid Neoplasms

Hematological Oncology, Volume 44, Issue 3, May 2026.
Francesco Tarantini, Cosimo Cumbo, Luisa Anelli, Antonella Zagaria, Nicoletta Coccaro, Angela Minervini, Giuseppina Tota, Elisa Parciante, Immacolata Redavid, Maria Rosa Conserva, Crescenzio Francesco Minervini, Angelo Cellamare, Paola Casieri, Maria Cristina Nuzzi, Paola Caforio, Alessandra Ricco, Giorgina Specchia, Pellegrino Musto, Francesco Albano   +18 more
wiley   +1 more source